NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

IC,

How do you feel this part from 10Q? I do think you need to give me credit for being the one who has been preaching the idea of NWBO collaboration with BPs.

The Company also continued discussions and negotiations during the first quarter of 2024 relating to collaborations which the Company believes will help it build a broad franchise in dendritic cell-based immunotherapies.

Look here are some examples of my preaching.

Size exclusion chromatography (SEC)

Size exclusion chromatography (SEC) is the analytical “gold standard” for the separation and accurate quantitation of aggregates, monomers, and lower molecular weight fragments contained in biotherapeutic peptides and proteins, including monoclonal antibody (mAbs) drugs.

Did…

— d_stock (@d_stock07734) March 30, 2024

scRNA-seq

Amgen
Postdoctoral Fellow – Immunology (autoimmunity and inflammation) https://t.co/8hlyzsT2id

Expertise with mouse handling, in vivo rodent models, multi-color flow cytometry, isolation and culture of primary human and mouse cells and cell lines, cell engineering, scRNA-seq,…

— d_stock (@d_stock07734) March 29, 2024

How do you think the vaccine manufacturing facility at Merck West Point campus is completed by the end of June 30? Wait a minute, did NWBO say ASM Would be held by the end of June? Any clue if the vaccine facility is related to DCVax-L. I knew the answer long time ago. I want to hear yours.